6FRJ | date | ![]() |
|||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
authors | |||||||||||||||
compound | source | ||||||||||||||
symmetry |
| ||||||||||||||
crystal cell |
| ||||||||||||||
method | X-Ray Diffraction | resolution | |||||||||||||
ligand | A2G, EDO, NH2, T9E | enzyme |
| ||||||||||||
Primary reference | Structure-Based Design of Potent Tumor-Associated Antigens: Modulation of Peptide Presentation by Single-Atom O/S or O/Se Substitutions at the Glycosidic Linkage., Companon I, Guerreiro A, Mangini V, Castro-Lopez J, Escudero-Casao M, Avenoza A, Busto JH, Castillon S, Jimenez-Barbero J, Asensio JL, Jimenez-Oses G, Boutureira O, Peregrina JM, Hurtado-Guerrero R, Fiammengo R, Bernardes GJL, Corzana F, J Am Chem Soc. 2019 Feb 20. doi: 10.1021/jacs.8b13503. PMID:30726084 |
Data retrieval |
![]() |
View 6FRJ in 3D |
![]() |
Structure-derived information |
Sequence-derived information |
OCA© by Jaime Prilusky, 1996-2014,2022,2024 Bioinformatics Unit Weizmann Institute of Science |